Ben Sidders

4PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 18, 2025
Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis.

James Boyle, Jan Zaucha, Felicia Ng

|Oct 11, 2023
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.

Maria Secrier, Lara McGrath, Felicia Ng

|Aug 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.

Emerson A Lim, Johanna C Bendell, Gerald S Falchook

|Aug 26, 2022
Cancer-driving mutations are enriched in genic regions intolerant to germline variation.

Dimitrios Vitsios, Ryan S Dhindsa, Dorota Matelska

Pageof 1

Frequent Collaborators

2 joint publications

Barrett R B Nuttall

2 joint publications

Emma V Jones

2 joint publications

Amelia Raymond

2 joint publications

Helen K Angell